I’m working with a T4-phage genome and obtained two different assemblies: one using a de novo strategy and the other using a reference genome. The reference-guided assembly resulted in a larger genome, and I noticed several differences between both versions.

This raised a concern: we often interpret differences as biological, but they might also stem from the assembly approach itself.

I would appreciate any insights on the criteria you use to evaluate assemblies, or any tools or approaches you recommend to compare and validate them.

Thanks in advance!

More Ana Juarez's questions See All
Similar questions and discussions